LWAYMEDIUM SIGNALFINANCIAL10-K

Lifeway Foods delivered strong profitability growth while experiencing a significant decline in cash reserves despite maintaining solid revenue expansion.

The company appears to be in a growth investment phase, with substantially higher net income demonstrating operational leverage, but the 67% cash decline suggests either significant capital deployment or working capital needs. The combination of higher inventory levels and reduced cash positions warrants monitoring of liquidity management, though the strong equity position provides a solid financial foundation.

Comparing 2026-03-17 vs 2025-03-14View on EDGAR →
FINANCIAL ANALYSIS

Lifeway showed robust operational performance with gross profit growing nearly 20% and net income substantially higher year-over-year, reflecting improved operational efficiency. However, the company's cash position dropped significantly to $5.6M while inventory increased 37%, suggesting active investment in growth or seasonal working capital needs. The overall financial picture remains healthy with total assets growing 17% and stockholders' equity increasing 19%, though the cash decline merits attention for liquidity planning.

FINANCIAL STATEMENT CHANGES
Cash & Equivalents
Balance Sheet
-66.7%
$16.7M→$5.6M

Cash declined 66.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Net Income
P&L
+53.6%
$9.0M→$13.9M

Net income grew 53.6% — bottom-line growth signals improving overall business health.

Interest Expense
P&L
+43.8%
$267K→$384K

Interest expense surged 43.8% — significant debt increase or rising rates materially impacting earnings.

Inventory
Balance Sheet
+37%
$8.7M→$11.9M

Inventory surged 37% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.

Total Debt
Balance Sheet
-26.7%
$3.8M→$2.8M

Debt reduced 26.7% — deleveraging strengthens balance sheet and reduces financial risk.

Gross Profit
P&L
+19.8%
$48.6M→$58.2M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Stockholders Equity
Balance Sheet
+19.3%
$71.9M→$85.8M

Equity base grew 19.3% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Operating Income
P&L
+16.7%
$13.9M→$16.2M

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Total Assets
Balance Sheet
+16.6%
$90.5M→$105.6M

Asset base grew 16.6% — expansion through organic growth, acquisitions, or capital deployment.

Operating Cash Flow
Cash Flow
-15.5%
$13.0M→$10.9M

Operating cash flow softened — monitor whether temporary working capital timing or structural deterioration.

LANGUAGE CHANGES
NEW — 2026-03-17
PRIOR — 2025-03-14
ADDED
As of March 2, 2026, 15,149,600 shares of the registrant s common stock, no par value, were outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations 1 9 Item 7A.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 29 Item 9A.
Unless otherwise noted herein, all amounts in this Form 10-K are in thousands, except per share numbers.
Net sales of products by category were as follows for the years ended December 31: 2025 2024 In thousands $ % $ % Drinkable Kefir other than ProBugs $ 181,423 85% $ 153,493 82% Cheese 16,571 8% 14,554 8% Cream and other 8,693 4% 8,299 4% Drinkable Yogurt 2,284 1% 5,619 3% Probugs Kefir 2,214 1% 3,421 2% Other dairy 1,311 1% 1,434 1% Net Sales $ 212,496 100% $ 186,820 100% 1 Product innovation and new product development Lifeway is committed to maintaining its position as the leading producer of kefir and a recognized leader in the market for probiotic products.
+7 more — sign up free →
REMOVED
As of March 14, 2025, 15,203,241 shares of the registrant s common stock, no par value, were outstanding.
Management s Discussion and Analysis of Financial Condition and Results of Operations 20 Item 7A.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 2 8 Item 9A.
Thanks to our exclusive blend of kefir cultures, each cup of our flagship low fat kefir contains 12 live and active cultures and 25 to 30 billion beneficial CFU (Colony Forming Units) at the time of manufacture.
Net sales of products by category were as follows for the years ended December 31: 2024 2023 In thousands $ % $ % Drinkable Kefir other than ProBugs $ 153,493 82% $ 127,726 80% Cheese 14,554 8% 13,781 9% Cream and other 8,299 4% 7,382 4% Drinkable Yogurt 5,619 3% 6,236 4% Probugs Kefir 3,421 2% 3,429 2% Other dairy 1,434 1% 1,569 1% Net Sales $ 186,820 100% $ 160,123 100% 1 Product innovation and new product development Lifeway is committed to maintaining its positions as the leading producer of kefir and a recognized leader in the market for probiotic products.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →